How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?

We suggested de-escalation would be possible for cervical cancer like human papillomavirus (HPV)-related oropharyngeal cancer. However, the classification was based on tumor shrinkage that can be obtained after half of the treatment was finished. Our other article found adverse factors which can be...

Descripción completa

Detalles Bibliográficos
Autores principales: Murakami, Naoya, Kuno, Ikumi, Yoshida, Hiroshi, Shiraishi, Kouya, Kato, Tomoyasu, Igaki, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Oncology/Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944302/
https://www.ncbi.nlm.nih.gov/pubmed/35039847
http://dx.doi.org/10.1093/jrr/rrab130
Descripción
Sumario:We suggested de-escalation would be possible for cervical cancer like human papillomavirus (HPV)-related oropharyngeal cancer. However, the classification was based on tumor shrinkage that can be obtained after half of the treatment was finished. Our other article found adverse factors which can be obtained prior to treatment, and they might classify patients earlier.

Ejemplares similares